175 results
Page 2 of 9
8-K
EX-99.1
pr18 s0lfv0
23 Feb 22
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
7:02am
8-K
EX-99.1
6q6 gw65whzbll37
8 Feb 22
BioCryst Appoints Machelle Sanders to Board of Directors
7:06am
8-K
EX-99.1
dcw2ye3gl1qufu
20 Sep 21
BioCryst Appoints Dr. Amy McKee to Board of Directors
7:06am
8-K
EX-99.1
a2rhrnp ayivgdfeck6m
26 Aug 21
BioCryst Appoints Dr. Steven Galson to Board of Directors
7:05am
8-K
EX-99.1
uer1yfj9h2iuovvkk
6 May 21
BioCryst Reports First Quarter 2021 Financial Results and Upcoming Key Milestones
7:09am
8-K
rymbmka9 e4k99vsp
22 Mar 21
Regulation FD Disclosure
8:07am
8-K
EX-99.1
2k1ajd zjs3e
22 Mar 21
Regulation FD Disclosure
8:07am
8-K
EX-99.1
vh318sxl75r74gv 490
25 Feb 21
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones
7:05am
8-K
EX-99.1
cr5n k2cu
22 Jan 21
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
7:12am
8-K
EX-99.1
mx2s2g94op342xb3
7 Dec 20
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
9:34am
8-K
EX-99.1
3hrpe
5 Nov 20
BioCryst Reports Third Quarter 2020 Financial Results and Upcoming Key Milestones
7:12am